The Practitioner - 1868-2018: Supporting general practitioners for 150 years - Triple antiplatelet therapy no better than standard regimens after ischaemic stroke
 
 
 
 
Login:
 
Savill P. Triple antiplatelet therapy no better than standard regimens after ischaemic stroke. Practitioner Jan 2018;262(1811):8-9

Triple antiplatelet therapy no better than standard regimens after ischaemic stroke

23 Jan 2018Registered users

Intensive antiplatelet therapy with three agents did not reduce the incidence and severity of recurrent stroke or transient ischaemic attack (TIA) but did significantly increase the risk of major bleeding in the TARDIS study.

Registered usersThis article can only be accessed if you are a registered user of thepractitioner.co.uk or a subscriber to The Practitioner.